Researchers report a swine influenza virus prevalent in China with the potential for pandemic spread in humans. Pigs are a key intermediate host, or “mixing vessel,” in the development of...

The U.S. Department of Health and Human Services (HHS) issued a six-year, $226 million contract today to increase capacity to produce recombinant influenza vaccine in the United States. The contract is...

Vivaldi Biosciences, a clinical-stage biotechnology company developing advanced vaccines for seasonal and pandemic influenza, recently announced the publication of Phase 1 clinical trial results for its...

Vaccitech Ltd. announced that it has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100) to the first participants in a Flu 010 study – a Phase 2b, randomised, double-blind, placebo...

The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety and tolerability as well as its ability to induce an immune response in healthy volunteers....

On the most recent episode of Outbreak News TV on YouTube, I talk to Senior Scholar at the Johns Hopkins Center for Health Security, Amesh Adalja, MD. He was named one of STAT’s “13 Clinicians...

My guest on today’s show is Amesh Adalja, MD. He is very familiar if you read news on various issues of infectious diseases and medicine as he is a frequent expert commenter. He was named one of...

My first guest on the new YouTube program, Outbreak News TV is public health scientist, infectious disease expert and director of the Center for Infectious Disease Research and Policy, or CIDRAP at the...

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to enable synthetic vaccine development in the field of infectious diseases, today announces that it has filed a patent...

This year marks the 100th anniversary of the 1918 influenza pandemic–history’s worst epidemic which killed more people than all the military deaths in World War I and World War II combined. Historian...